Francoise Imbert-Bismut
Overview
Explore the profile of Francoise Imbert-Bismut including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
1555
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weiss N, Tripon S, Mallet M, Imbert-Bismut F, Sakka M, Bonnefont-Rousselot D, et al.
J Intensive Med
. 2024 Apr;
4(2):222-230.
PMID: 38681783
Background: Hepatic encephalopathy (HE) is highly prevalent in patients with liver diseases. The pathophysiology of HE is centered on the synergic role of hyperammonemia and systemic inflammation. However, some data...
2.
Hanin A, Demeret S, Lambrecq V, Rohaut B, Marois C, Bouguerra M, et al.
J Neurol
. 2022 Jun;
269(11):5868-5882.
PMID: 35768546
Prediction of mortality, functional outcome and recovery after status epilepticus (SE) is a challenge. Biological and clinical markers have been proposed to reflect the brain injury or to monitor critical...
3.
Hanin A, Denis J, Frazzini V, Cousyn L, Imbert-Bismut F, Rucheton B, et al.
J Neurol
. 2022 Feb;
269(7):3752-3760.
PMID: 35190890
Status epilepticus (SE) is a life-threatening prolonged epileptic seizure. A rapid diagnosis is fundamental to initiate antiepileptic treatment and to prevent the development of neurological sequels. Several serum and cerebrospinal...
4.
Dana J, Girard M, Franchi-Abella S, Berteloot L, Benoit-Cherifi M, Imbert-Bismut F, et al.
Clin Res Hepatol Gastroenterol
. 2021 Dec;
46(3):101855.
PMID: 34933150
Background And Objective: Reliable markers are needed for early diagnosis and follow-up of liver disease in Cystic Fibrosis (CF). The objective was to evaluate the diagnostic performance of Transient Elastography...
5.
Hanin A, Demeret S, Denis J, Nguyen-Michel V, Rohaut B, Marois C, et al.
Eur J Neurol
. 2021 Oct;
29(3):883-889.
PMID: 34687105
Background And Purpose: There is a need for accurate biomarkers to monitor electroencephalography (EEG) activity and assess seizure risk in patients with acute brain injury. Seizure recurrence may lead to...
6.
Imbert-Bismut F, Payet P, Alfaisal J, Munteanu M, Rudler M, Sultanik P, et al.
Clin Chim Acta
. 2020 Aug;
510:522-530.
PMID: 32735981
Background: Hyperammonemia is neurotoxic and as such can be a medical emergency. Preanalytical factors greatly influence the blood ammonia concentration results. Aims And Methods: Ammonia concentrations measured in the real...
7.
Hanin A, Lambrecq V, Denis J, Imbert-Bismut F, Rucheton B, Lamari F, et al.
Epilepsia
. 2019 Dec;
61(1):6-18.
PMID: 31828792
Status epilepticus is a condition resulting either from the failure of the mechanisms responsible for seizure termination or from the initiation of mechanisms that lead to abnormally prolonged seizures and...
8.
Poynard T, Peta V, Deckmyn O, Pais R, Ngo Y, Charlotte F, et al.
Eur J Gastroenterol Hepatol
. 2019 Dec;
32(8):998-1007.
PMID: 31789950
Objective: There is a controversy about the performance of blood tests for the diagnostic of metabolic liver disease in patients with type-2-diabetes in comparison with patients without type-2-diabetes. These indirect...
9.
Poynard T, Peta V, Deckmyn O, Munteanu M, Moussalli J, Ngo Y, et al.
Aliment Pharmacol Ther
. 2018 Dec;
49(3):308-320.
PMID: 30569507
Background: No blood test has been shown to be effective in the prediction of primary liver cancer in patients without cirrhosis. Aim: To construct and internally validate two sequential tests...
10.
Munteanu M, Pais R, Peta V, Deckmyn O, Moussalli J, Ngo Y, et al.
Aliment Pharmacol Ther
. 2018 Oct;
48(10):1117-1127.
PMID: 30334263
Background: Although the FibroTest has been validated as a biomarker to determine the stage of fibrosis in non-alcoholic fatty liver disease (NAFLD) with results similar to those in chronic hepatitis...